Out of 17,868 discharged diabetes patients who were alive after a first event of MI, 365 (2%) were using GLP-1 RAs, which was associated with a lower event risk after median 3 years of follow-up (adjusted HR 0.72), mainly attributed to a lower risk of reinfarction and stroke with no suggestion of heterogeneity across subgroups of age, sex, chronic kidney disease, and STEMI. Here, GCG is linked to diabetes mellitus.